New Partnership Connects Leadership Excellence to Improved Post-Acute Care 
Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27
ARLINGTON, Va., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to...
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology
- University of Utah Hospital, Lori Gawron, M.D. of the Obstetrics and Gynecology (OB/GYN) Department, was an instrumental investigator in...
Alkeus Pharmaceuticals Appoints Seemi Khan, M.D., Chief Medical Officer
CAMBRIDGE, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced that Seemi Khan, M.D., M.P.H., M.B.A., has...
Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
SOLANA BEACH, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling...
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced...
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently...
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T...
Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
REDWOOD CITY, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative...
Recce Pharmaceuticals Reports Positive Phase I/II Trial Results of RECCE® 327 for the Treatment of Diabetic Foot Infections
Phase I/II trial assessing the safety and efficacy of RECCE® 327 (R327), a broad-spectrum anti-infective as a topical treatment, met...
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber’s Hereditary Optic Neuropathy (LHON)
NAYA to accelerate Phase II clinical development and Early Patient Access after initial safety demonstrated in 28-patient clinical trialProgram developed...
InnovAge to Announce Fiscal Second Quarter 2024 Financial Results and Host Conference Call Tuesday, February 6, 2024
DENVER, Jan. 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in...
PMDS Share Price Increase
STOCKHOLM, SE / ACCESSWIRE / January 23, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) During today's initial trading, the price of...
Optimizing Healthcare Communications with WestFax CloudFax Toolkit
DENVER--(BUSINESS WIRE)--#WestFax--WestFax proudly unveils its latest advancement in healthcare secure cloud fax technology: the CloudFax Toolkit (CFT). This toolkit is...
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and...
MyndTec Inc. Receives Statement of Claim and Intends to Defend Itself
Mississauga, Ontario--(Newsfile Corp. - January 22, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a medical technology company,...
ASTCT, AACI, and ACCC Launch RECUR Initiative to Enhance Patient Access to CAR T Therapy
CHICAGO, IL / ACCESSWIRE / January 22, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT), the Association...
JDRF Awards $9 Million US for Phase 3 Type 1 Diabetes Kidney Disease Clinical Trial, Joins The Kidney Foundation of Canada in Driving Research to Treat Kidney Disease
New York, New York and Montreal, Quebec--(Newsfile Corp. - January 22, 2024) - JDRF, the leading global type 1 diabetes...
The Ketamine Story: Transforming Treatment for Mood Disorders and Pain
Free webinar on ketamine therapy - Mon, Feb 5, 2024, 6PM PSTPALM SPRINGS, CA / ACCESSWIRE / January 22, 2024...
ZetrOZ Systems to Showcase sam(R) Ultrasound Treatment Technology at the 2024 Big Sky Sports Medicine Conference
Presentations at long-running, prestigious meeting will focus on effectiveness of sustained acoustic medicine in soft tissue healing.TRUMBULL, CT / ACCESSWIRE...
Evolution Devices’ EvoWalk Device to Rehabilitate Walking Receives FDA 510(k) Clearance
The EvoWalk 1.0 System, designed to improve walking through AI-based functional electrical stimulation, now has FDA clearance.OAKLAND, CA / ACCESSWIRE...